U.S. Raises Ante in Vaccine Race With $1.2 Billion for Astra
Vials travel from the filling section to the packaging section of the production line at AstraZeneca’s new Biologics factory in Sodertalje, Sweden. (Photographer: Mikael Sjoberg/Bloomberg)

U.S. Raises Ante in Vaccine Race With $1.2 Billion for Astra

(Bloomberg) --
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.